Bayer, Merck Sign Master Settlement Agreements For Fluoroquinolone MDL Cases

(January 7, 2019, 1:56 PM EST) -- MINNEAPOLIS — The Minnesota federal judge overseeing the fluoroquinolone multidistrict litigation on Jan. 2 said in a pretrial order that defendants Bayer Healthcare Pharmaceuticals Inc. and Merck & Co. Inc. have...

To view the full article, register now.